SAN FRANCISCO--(BUSINESS WIRE)--AdeTherapeutics, Inc., a world leader in developing products that reduce fibrosis or scar tissue (adhesion) complications related to surgery, today announced the company has retained Beal Advisors, a boutique investment bank located in San Francisco, to conduct a formal process to evaluate strategic options that have become available to the company.
